GlassScriptPhysician profile
Laresa West
NPI 1710357926
$2,586.66
in general payments reported to CMS, 2019-2025
32 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $462 · 2022: $551 · 2023: $501 · 2024: $651 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,489 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,489.06 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $796.99 | 2022-2025 | Interstim, Altaviva |
| Astellas Pharma US INC | $257.41 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $227.53 | 2022-2025 | Prolaris |
| Abbvie INC. | $210.44 | 2021-2025 | |
| Janssen Biotech, INC. | $151.89 | 2022-2025 | Erleada |
| Sumitomo Pharma America, INC. | $116.41 | 2023-2024 | Orgovyx, Gemtesa |
| 180 Medical, INC. | $80.24 | 2021-2022 | |
| Boston Scientific Corporation | $75.16 | 2023-2025 | Spaceoar System, General - Pain Management, Ams 700 |
| Blue Earth Diagnostics | $69.71 | 2021-2023 | |
| Myovant Sciences INC. | $50.61 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $49.66 | 2025 | Keytruda, Lynparza |
| Coloplast Corp | $44.71 | 2024-2025 | |
| Urogen Pharma, INC. | $42.81 | 2022-2024 | |
| Endo USA, INC. | $39.93 | 2024-2025 | Xiaflex |
| Rochester Medical Corporation | $38.46 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $32.44 | 2021-2022 | |
| Olympus America INC. | $31.68 | 2022-2025 | Itind System |
| Janssen Pharmaceuticals, INC | $28.28 | 2025 | Erleada |
| Immunitybio, INC. | $22.61 | 2025 | |
| Dendreon Pharmaceuticals LLC | $22.11 | 2021 | |
| Abc Home Medical Supply, INC. | $20.38 | 2022 | |
| Endo Pharmaceuticals INC. | $19.72 | 2024 | Aveed, Xiaflex |
| Glaxosmithkline, LLC. | $18.37 | 2022 | |
| Pfizer INC. | $17.54 | 2025 | |
| Antares Pharma, INC. | $16.76 | 2022 | |
| Tolmar, INC. | $16.41 | 2025 | Eligard, Jatenzo |
| Astrazeneca Pharmaceuticals LP | $16.19 | 2022 | |
| Calyxo, INC. | $15.90 | 2024 | Cvac Aspiration System |
| Clarus Therapeutics INC. | $15.74 | 2021 | |
| Agiliti Surgical, INC. | $14.26 | 2025 | Boston Scientific Lumenis Pulse 120h Holmium Laser W/ Moses Technology, Quanta System Fiber Dust Tfl Laser, Olympus Soltive Tfl Laser |
| Ambu INC. | $13.46 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laresa West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.